Andreja Marn Pernat

Prof. Dr. Andreja Marn Pernat


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2016 in BMJ Open Diabetes Research & Care
Verified
Journal Article
Open access
PDF file
APAndreja Marn Pernat
Andreja Marn Pernat
VPVanja Peršič
Vanja Peršič
LULen Usvyat
Len Usvyat
LSLynn Saunders
Lynn Saunders
JRJohn Rogus
John Rogus
Peter KotankoPeter Kotanko
Peter Kotanko
Objective Patients with diabetes are at increased risk of foot ulcers, which may result in limb amputations. While regular foot care prevents ulcerations and amputation in those patients with diabetes not on dialysis, evidence is limited in diabetic hemodialysis patients. We investigated the association between the implementation of a routine foot check program in diabetic incident hemodialysis patients, and major lower limb amputations. Methods In 1/2008, monthly intradialytic foot checks were implemented as part of standard clinic care in all Fresenius Medical Care North America hemodialysis facilities. Patients with diabetes who initiated hemodialysis between 1/2004 and 12/2007 constituted the preimplementation cohort, and patients starting hemodialysis between 1/2008 and 12/2011 comprised the postimplementation cohort. In addition, we conducted a sensitivity analysis where we excluded patients from the clinics with <10 patients in the postimplementation period and where percent difference in patient with diabetes number between postimplementation and preimplementation period was <20%. We compared lower limb amputation rates employing Poisson regression models with offset of exposure time in these two cohorts. Results We studied 35 513 patients in the preimplementation and 25 779 patients in the postimplementation cohort. In the postimplementation cohort, amputation rate decreased by 17% (p=0.0034). The major lower limb amputation rate was 1.30 per 100 patient years in preimplementation and 1.07 in postimplementation cohort. These beneficial results were corroborated in the multivariate analysis (p=0.0175) and were even more pronounced in the sensitivity analysis (p=0.0083). Conclusion Monthly foot checks are associated with reduction of major lower limb amputations in diabetic incident hemodialysis patients.

31 July 2009 in Therapeutic Apheresis and Dialysis
Verified
Journal Article
Closed access
PDF file
APAndreja Marn Pernat
Andreja Marn Pernat
JBJadranka Buturović‐Ponikvar
Jadranka Buturović‐Ponikvar
VŠViktor Švigelj
Viktor Švigelj
RPRafael Ponikvar
Rafael Ponikvar

16 December 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MZMatej Zrimsek
Matej Zrimsek
Jakob GubensekJakob Gubensek
Jakob Gubensek
APAndreja Marn Pernat
Andreja Marn Pernat
Background: Therapeutic plasma exchange (TPE) removes coagulation factors and leads to depletion coagulopathy. The aim of the study was to compare hemostasis between TPE procedures without coagulation factor replacement (electrolyte group), the partial replacement of fibrinogen with fibrinogen concentrates (fibrinogen group) and partial coagulation factors replacement with fresh frozen plasma (partial FFP group). Methods: A total of 73 TPE procedures in patients with fibrinogen levels 1–2 g/L were divided into three study groups depending on clinically estimated bleeding risk. Standard coagulation and ROTEM® tests were performed before and after TPE. Results: Fibrinogen levels before TPE (p = 0.88) and after TPE (p = 0.33) were comparable between the fibrinogen and partial FFP groups. INR and ROTEM® parameters reflected moderately worse hemostasis after TPE with fibrinogen-only replacement compared to partial FFP replacement, which could result in increased bleeding risk. In the electrolyte group, most laboratory tests confirmed the most deranged hemostasis after TPE, as compared to fibrinogen or partial FFP replacement. A mild allergic reaction to FFP infusion was noted during one TPE. No clinically significant bleeding occurred in any of the study groups. Conclusions: Fibrinogen concentrate supplementation and partial FFP replacement can both maintain fibrinogen levels > 1 g/L after TPE, but modest differences in classical coagulation tests and bedside ROTEM® tests favor FFP replacement (NCT03801135).

21 June 2005 in Therapeutic Apheresis and Dialysis
Verified
Journal Article
Closed access
PDF file
APAndreja Marn Pernat
Andreja Marn Pernat
JBJadranka Buturović‐Ponikvar
Jadranka Buturović‐Ponikvar
MLMartina Logar
Martina Logar
MHMilena Horvat
Milena Horvat
RPRafael Ponikvar
Rafael Ponikvar

31 July 2009 in Therapeutic Apheresis and Dialysis
Verified
Journal Article
Closed access
PDF file
APAndreja Marn Pernat
Andreja Marn Pernat
JBJadranka Buturović‐Ponikvar
Jadranka Buturović‐Ponikvar
JKJanko Kovač
Janko Kovač
BKBojan Knap
Bojan Knap
VPVladimir Premru
Vladimir Premru
RPRafael Ponikvar
Rafael Ponikvar

16 June 2016 in Therapeutic Apheresis and Dialysis
Verified
Journal Article
Closed access
PDF file
APAndreja Marn Pernat
Andreja Marn Pernat
BMBojan Medved
Bojan Medved
Jakob GubensekJakob Gubensek
Jakob Gubensek
VPVladimir Premru
Vladimir Premru
BKBojan Knap
Bojan Knap
RPRafael Ponikvar
Rafael Ponikvar